TG Therapeutics Inc (TGTX)

Working capital turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 329,004 262,359 340,582 280,254 222,343 180,883 18,875 6,331 2,784 5,025 6,961 7,912 6,689 4,406 2,414 907 152 152 152 152
Total current assets US$ in thousands 566,359 574,069 389,150 360,581 317,943 319,114 208,574 184,783 168,274 182,922 202,560 242,216 330,965 371,779 455,068 535,013 611,740 260,335 280,938 88,016
Total current liabilities US$ in thousands 90,679 125,114 108,664 99,684 53,720 57,678 72,667 63,076 53,201 36,447 43,326 54,656 65,384 87,655 87,551 92,494 87,554 77,670 67,537 63,118
Working capital turnover 0.69 0.58 1.21 1.07 0.84 0.69 0.14 0.05 0.02 0.03 0.04 0.04 0.03 0.02 0.01 0.00 0.00 0.00 0.00 0.01

December 31, 2024 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $329,004K ÷ ($566,359K – $90,679K)
= 0.69

Working capital turnover measures how efficiently a company utilizes its working capital to generate sales revenue. A higher ratio indicates better efficiency in utilizing working capital to generate sales.

For TG Therapeutics Inc, the working capital turnover has shown fluctuations over the quarters. From a low of 0.00 in June 2020, the ratio gradually increased to reach 1.21 by June 2024. This indicates a significant improvement in the efficiency of working capital utilization over the analyzed period.

The company's working capital turnover ratio reached its peak at 1.21 in June 2024, suggesting that TG Therapeutics Inc was able to generate $1.21 in sales for every dollar of working capital invested. This signifies an efficient use of working capital resources to drive revenue growth.

Overall, the trend of increasing working capital turnover ratio indicates that TG Therapeutics Inc has been effectively managing its working capital to support sales growth and enhance operational efficiency.